Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Dodds

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nature Biotechnology|November 18, 2022
Improving combination drug trials using 'definitive screening designs'Michael Dodds, James Roberts, Brian Finrow
Journal of Agricultural and Food Chemistry|November 15, 2008
Naturally occurring phenolic antibacterial compounds show effectiveness against oral bacteria by a quantitative structure-activity relationship studyMichael Greenberg, Michael Dodds, Minmin Tian
Skeletal Radiology|October 17, 2020
Multimodal imaging of composite carbon fiber-based implants for orthopedic spinal fixationFrancis T Delaney, Hazel Denton, Michael Dodds, et al.
Plos One|August 26, 2015
Factors That Influence the Extensional Rheological Property of SalivaAmrita Vijay, Taichi Inui, Michael Dodds, et al.
British Journal of Clinical Pharmacology|April 19, 2020
Dosing will be a key success factor in repurposing antivirals for COVID-19Patrick F Smith, Michael Dodds, Darren Bentley, et al.
Clinical Pharmacokinetics|July 3, 2021
Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, Michael Dodds, Timothy Mack, et al.
Clinical Pharmacokinetics|June 14, 2021
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, Michael Dodds, Timothy Mack, et al.
Journal of the American Dental Association (1939)|May 5, 2025
Cannabis Use and HyposalivationMichael Dodds, Clifton M Carey, Margaret Scarlett, et al.
Chemical Science|March 15, 2024
Sample efficient reinforcement learning with active learning for molecular designMichael Dodds, Jeff Guo, Thomas Löhr, et al.
Frontiers in Immunology|November 15, 2024
Comparative pharmacokinetics of porcine and human anti-influenza hemagglutinin monoclonal antibodies in outbred pigs and minipigsBasudev Paudyal, Elliot Moorhouse, Bhawna Sharma, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nature Biotechnology|November 18, 2022
Improving combination drug trials using 'definitive screening designs'Michael Dodds, James Roberts, Brian Finrow
Journal of Agricultural and Food Chemistry|November 15, 2008
Naturally occurring phenolic antibacterial compounds show effectiveness against oral bacteria by a quantitative structure-activity relationship studyMichael Greenberg, Michael Dodds, Minmin Tian
Skeletal Radiology|October 17, 2020
Multimodal imaging of composite carbon fiber-based implants for orthopedic spinal fixationFrancis T Delaney, Hazel Denton, Michael Dodds, et al.
Plos One|August 26, 2015
Factors That Influence the Extensional Rheological Property of SalivaAmrita Vijay, Taichi Inui, Michael Dodds, et al.
British Journal of Clinical Pharmacology|April 19, 2020
Dosing will be a key success factor in repurposing antivirals for COVID-19Patrick F Smith, Michael Dodds, Darren Bentley, et al.
Clinical Pharmacokinetics|July 3, 2021
Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, Michael Dodds, Timothy Mack, et al.
Clinical Pharmacokinetics|June 14, 2021
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell LymphomaKen Ogasawara, Michael Dodds, Timothy Mack, et al.
Journal of the American Dental Association (1939)|May 5, 2025
Cannabis Use and HyposalivationMichael Dodds, Clifton M Carey, Margaret Scarlett, et al.
Chemical Science|March 15, 2024
Sample efficient reinforcement learning with active learning for molecular designMichael Dodds, Jeff Guo, Thomas Löhr, et al.
Frontiers in Immunology|November 15, 2024
Comparative pharmacokinetics of porcine and human anti-influenza hemagglutinin monoclonal antibodies in outbred pigs and minipigsBasudev Paudyal, Elliot Moorhouse, Bhawna Sharma, et al.
Pageof 3